WallStSmart

DocGo Inc (DCGO)vsThe Ensign Group Inc (ENSG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 1470% more annual revenue ($5.06B vs $322.20M). ENSG leads profitability with a 6.8% profit margin vs -56.6%. ENSG earns a higher WallStSmart Score of 57/100 (C).

DCGO

Hold

36

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 3/9Altman Z: 1.88

ENSG

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 8.0Quality: 5.8
Piotroski: 5/9Altman Z: 2.34
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DCGO.

ENSGFair Value (-0.3%)

Margin of Safety

-0.3%

Fair Value

$211.28

Current Price

$203.89

$7.39 premium

UndervaluedFair: $211.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DCGO2 strengths · Avg: 9.5/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.119/10

Conservative balance sheet, low leverage

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

Areas to Watch

DCGO4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.884/10

Grey zone — moderate risk

Market CapQuality
$66.57M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-89.0%2/10

ROE of -89.0% — below average capital efficiency

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

Comparative Analysis Report

WallStSmart Research

Bull Case : DCGO

The strongest argument for DCGO centers on Price/Book, Debt/Equity.

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bear Case : DCGO

The primary concerns for DCGO are Altman Z-Score, Market Cap, Piotroski F-Score.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Key Dynamics to Monitor

DCGO profiles as a turnaround stock while ENSG is a growth play — different risk/reward profiles.

DCGO carries more volatility with a beta of 0.96 — expect wider price swings.

ENSG is growing revenue faster at 20.2% — sustainability is the question.

ENSG generates stronger free cash flow (133M), providing more financial flexibility.

Bottom Line

ENSG scores higher overall (57/100 vs 36/100) and 20.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DocGo Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

DocGo Inc. is an innovative mobile healthcare service provider revolutionizing patient access through its advanced logistics and telehealth platform. Specializing in urgent care, diagnostic testing, and health screenings, the company enhances patient experiences while streamlining healthcare delivery across diverse environments. With strong technological integration and a commitment to expanding quality healthcare access, DocGo is well-positioned for substantial growth in the rapidly evolving healthtech sector, making it an attractive investment opportunity for institutional investors.

Visit Website →

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

Want to dig deeper into these stocks?